Related Experiment Videos
Effects of urinary macromolecules on hydroxyapatite crystal formation
Ann M Beshensky1, Jeffrey A Wesson1, Elaine M Worcester1
1Nephrology Division, Department of Veterans Affairs Medical Center and the Medical College of Wisconsin, Milwaukee, Wisconsin.
Journal of the American Society of Nephrology : JASN
|September 20, 2001
Summary
Urinary macromolecules influence hydroxyapatite (HA) crystal formation by affecting growth, nucleation, and aggregation independently. Understanding these interactions is key to preventing kidney stone formation.
Area of Science:
- Biomineralization
- Crystallization kinetics
- Renal stone research
Background:
- Hydroxyapatite (HA) crystal formation is a complex process influenced by various factors in biological systems.
- Urinary macromolecules play a significant role in modulating HA crystallization, impacting stone formation.
- Understanding the specific effects of these macromolecules on nucleation, growth, and aggregation is crucial for therapeutic interventions.
Purpose of the Study:
- To investigate the effects of specific urinary macromolecules on hydroxyapatite (HA) crystal nucleation, growth, and aggregation.
- To determine how different macromolecules differentially affect the various stages of HA crystallization.
- To assess the utility of combining particle size analysis with titration data for a comprehensive understanding of crystallization behavior.
Main Methods:
- Combined particle size analysis with titration data in constant-composition, HA-seeded crystal growth assays.
- Utilized varying amounts of HA seeds (250 microg and 62.5 microg) to differentiate between growth and nucleation.
- Examined the effects of osteopontin (OPN), recombinant glutathione-S-transferase-OPN (G-OPN), Tamm-Horsfall protein, chondroitin sulfate, human serum albumin, stone-former urinary macromolecules (SFU1), normal urinary macromolecules (NU1), and polyaspartic acid (PA).
Main Results:
- Polyaspartic acid (PA), G-OPN, OPN, SFU1, and NU1 inhibited crystal growth, while all tested macromolecules inhibited aggregation.
- Macromolecules that inhibited growth also increased secondary nucleation, with OPN, G-OPN, PA, SFU1, and NU1 being most effective.
- Recombinant G-OPN showed less inhibition than OPN; chondroitin sulfate and human serum albumin had no significant effects; SFU1 and NU1 affected growth and nucleation similarly but not aggregation.
Conclusions:
- Urinary macromolecules independently affect HA crystal nucleation, growth, and aggregation, likely due to structural differences.
- The combined approach of particle size analysis and titration provides deeper insights into crystallization behavior than individual methods.
- These findings highlight the complex interplay of macromolecules in HA crystallization and offer potential targets for kidney stone prevention strategies.